Biotech Values

[St_armands_man]

Dew - to your comment:
One more wildcard: it would not be completely shocking to see Pharming try to exploit this delay with a offer to buy GTCB

Actually, I was thinking exactly the same thing a bit earlier. At this price point, depending what else they're looking at in terms of partnership arrangements, etc., it would potentially be on the table.

As you stated - not likely, but definately a possibility.